Scientists at the Broad Institute of MIT and Harvard in the US have developed a new computational method called CATCH, which could enable the design of molecular ‘baits’ for any known human virus and all their strains.

The new technique is intended to enable the detection of even low-abundance viruses such as Zika.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Certain existing methods such as metagenomic sequencing and enrichment of clinical samples either miss viral material or are directed at a single microbe.

“The new technique is intended to enable the detection of even low-abundance viruses such as Zika.”

To address these challenges, the team created a computational method to design probes that could offer a comprehensive analysis of different microbes in clinical samples, as well as enrich for low-abundance microbes.

MIT graduate student Hayden Metsky said: “We wanted to rethink how we were actually designing the probes to do capture. We realised that we could capture viruses, including their known diversity, with fewer probes than we’d used before.

“To make this an effective tool for surveillance, we then decided to try targeting about 20 viruses at a time, and we eventually scaled up to the 356 viral species known to infect humans.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The ‘bait’ design of the CATCH probes facilitates capture of genetic material of any combination of viruses.

Users can run the new computational method by inputting genomes from all forms of human viruses available on GenBank sequence database of the National Center for Biotechnology Information.

The programme establishes the best set of probes depending on what the patient needs to recover, irrespective of all viruses or only a subset.

These probes can be used to identify and study the microbes by capturing desired microbial DNA for sequencing, in turn enriching the samples.

Testing of the probes showed that viral content made up more of the sequencing data after enrichment.

The researchers believe that CATCH can aid small sequencing centres in efficient and cost-effective disease surveillance, delivering the information required to control outbreaks.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact